These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12710884)

  • 21. [Type B natriuretic peptide. Role in heart failure physiopathology, diagnosis, and prognosis].
    Bettencourt P; Azevedo A
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II95-104. PubMed ID: 15222253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain natriuretic peptide and optimal management of heart failure.
    Li N; Wang JA
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):877-84. PubMed ID: 16130189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin.
    Kalra PR; Anker SD; Coats AJ
    Cardiovasc Res; 2001 Aug; 51(3):495-509. PubMed ID: 11476740
    [No Abstract]   [Full Text] [Related]  

  • 24. Brain natriuretic peptide in the contemporary management of congestive heart failure.
    Wasywich CA; Whalley GA; Doughty RN
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):71-84. PubMed ID: 15723576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac and intestinal natriuretic peptides: insights from genetically modified mice.
    Kuhn M
    Peptides; 2005 Jun; 26(6):1078-85. PubMed ID: 15911075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New CHF drug shown to ease breathing distress among hospitalized patients.
    Clin Resour Manag; 2002 May; 3(5):68-70, 65. PubMed ID: 12048768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review.
    Woods RL
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):791-4. PubMed ID: 15566395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nesiritide for decompensated congestive heart failure.
    Med Lett Drugs Ther; 2001 Nov; 43(1118):100-1. PubMed ID: 11707752
    [No Abstract]   [Full Text] [Related]  

  • 29. Is there a common mechanism of benefit for effective treatment of heart failure?
    Cohn JN
    Eur J Heart Fail; 1999 Mar; 1(1):31-4. PubMed ID: 10937976
    [No Abstract]   [Full Text] [Related]  

  • 30. A review of the natriuretic hormone system's diagnostic and therapeutic potential in critically ill children.
    Costello JM; Goodman DM; Green TP
    Pediatr Crit Care Med; 2006 Jul; 7(4):308-18. PubMed ID: 16760825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Brain natriuretic peptide and heart failure].
    Camici M
    Minerva Med; 2005 Apr; 96(2):77-86. PubMed ID: 16172577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic peptides and remodeling in heart failure.
    Burnett JC
    Heart Fail Clin; 2005 Apr; 1(1):129-39. PubMed ID: 17386839
    [No Abstract]   [Full Text] [Related]  

  • 33. Recommendations for the clinical use of cardiac natriuretic peptides.
    Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G; ; ; ; ; ;
    Ital Heart J; 2005 May; 6(5):430-46. PubMed ID: 15934421
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of natriuretic peptides in cardioprotection.
    Nishikimi T; Maeda N; Matsuoka H
    Cardiovasc Res; 2006 Feb; 69(2):318-28. PubMed ID: 16289003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional sampling and the effects of experimental heart failure in sheep: differential responses in A, B and C-type natriuretic peptides.
    Charles CJ; Prickett TC; Espiner EA; Rademaker MT; Richards AM; Yandle TG
    Peptides; 2006 Jan; 27(1):62-8. PubMed ID: 16095755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers in heart failure management.
    Isaac DL
    Curr Opin Cardiol; 2008 Mar; 23(2):127-33. PubMed ID: 18303525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
    Mehra MR; McCluskey T; Barr M; Bourge RC; Jessup ML; Mancini D; Radovancevic B; Rayburn B; Taylor DO; Lilly-Hersley J; Linde P
    Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1.
    Petrie MC; McClure SJ; Love MP; McMurray JJ
    Eur J Heart Fail; 1999 Mar; 1(1):25-9. PubMed ID: 10937975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.